We are live on ! Find out more
PSTX

Poseida Therapeutics, Inc. Common Stock
PSTX

Delisted

PSTX was delisted on the 7th of January, 2025.

Back to rankings

1 hedge funds and large institutions have $308K invested in Poseida Therapeutics, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 113 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 115 → 1 (-114)

100% less capital invested

Capital invested by funds: $519M → $308K (-$519M)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 113

Holders
1
Holders Change
-114
Holders Change %
-99.13%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
113
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$96.1M
2
PCM
Pentwater Capital Management
Florida
-$82.8M
3
BlackRock
BlackRock
New York
-$54.1M
4
Nomura Holdings
Nomura Holdings
Japan
-$49.1M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$36.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
– -$2.65M -275,990 Closed
Renaissance Technologies
27
Renaissance Technologies
New York
– -$2.6M -271,200 Closed
WAM
28
Weiss Asset Management
Massachusetts
– -$2.24M -233,424 Closed
OAC
29
OMERS Administration Corp
Ontario, Canada
– -$2.15M -224,000 Closed
Arrowstreet Capital
30
Arrowstreet Capital
Massachusetts
– -$2.15M -223,990 Closed
Bank of New York Mellon
31
Bank of New York Mellon
New York
– -$1.94M -201,957 Closed
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
– -$1.9M -198,375 Closed
YCM
33
Yakira Capital Management
Connecticut
– -$1.7M -177,404 Closed
JP Morgan Chase
34
JP Morgan Chase
New York
– -$1.7M -176,956 Closed
Walleye Capital
35
Walleye Capital
New York
– -$1.66M -172,459 Closed
Citadel Advisors
36
Citadel Advisors
Florida
– -$1.49M -154,764 Closed
Connor, Clark & Lunn Investment Management (CC&L)
37
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$1.47M -153,058 Closed
DAM
38
Deltec Asset Management
New York
– -$1.44M -150,000 Closed
Marshall Wace
39
Marshall Wace
United Kingdom
– -$1.4M -146,232 Closed
Mirae Asset Global ETFs Holdings
40
Mirae Asset Global ETFs Holdings
Hong Kong
– -$1.36M -141,339 Closed
Millennium Management
41
Millennium Management
New York
– -$1.31M -136,116 Closed
ACM
42
ADAR1 Capital Management
Texas
– -$1.29M -134,109 Closed
UBS Group
43
UBS Group
Switzerland
– -$1.16M -120,549 Closed
MG
44
Marex Group
– -$1.13M -118,161 Closed
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
– -$1.09M -113,431 Closed
Barclays
46
Barclays
United Kingdom
– -$1.01M -104,822 Closed
RC
47
Rangeley Capital
Connecticut
– -$934K -97,300 Closed
CC
48
CIBRA Capital
United Kingdom
– -$907K -94,495 Closed
Bank of America
49
Bank of America
North Carolina
– -$833K -86,796 Closed
AI
50
Atom Investors
Texas
– -$795K -82,856 Closed
1
2
3 4 5

PSTX Hedge Fund Activity: Q1 2025 in Review

1 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Poseida Therapeutics, Inc. Common Stock (PSTX) for Q1 2025, worth a combined $308K — down 100% from $519M a quarter earlier.

Sellers outnumbered buyers: 113 funds closed out of PSTX and 0 opened new positions — a net loss of 113 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Fidelity Investments, exiting entirely with an estimated $96.1M sold.

  • 1 institutional investor held Poseida Therapeutics, Inc. Common Stock (PSTX) as of Q1 2025, down from 115 in Q4 2024.
  • Funds reported $308K of Poseida Therapeutics, Inc. Common Stock stock for Q1 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Poseida Therapeutics, Inc. Common Stock positions in Q1 2025 and 113 closed out, a net change of -113 holders.
  • The largest Poseida Therapeutics, Inc. Common Stock seller in Q1 2025 was Fidelity Investments, an estimated $96.1M sold.

Based on aggregated 13F filings for Q1 2025.